Magda Michna
Chief Tech/Sci/R&D Officer bei STAAR SURGICAL COMPANY
Vermögen: 537 719 $ am 31.03.2024
Profil
Magda Michna is currently the Chief Clinical & Medical Affairs Officer at STAAR Surgical Co. Prior to this role, she served as the Head-Chief Global Clinical & Medical Officer at AcuFocus, Inc. from 2018 to 2023.
From 2012 to 2017, she was the Chief Clinical Officer at Presbia PLC.
Dr. Michna holds undergraduate and doctorate degrees from the University of Melbourne.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
STAAR SURGICAL COMPANY
0,03% | 12.03.2024 | 14 047 ( 0,03% ) | 537 719 $ | 31.03.2024 |
Aktive Positionen von Magda Michna
| Unternehmen | Position | Beginn |
|---|---|---|
| STAAR SURGICAL COMPANY | Chief Tech/Sci/R&D Officer | 01.04.2023 |
Ehemalige bekannte Positionen von Magda Michna
| Unternehmen | Position | Ende |
|---|---|---|
AcuFocus, Inc.
 AcuFocus, Inc. Medical SpecialtiesHealth Technology AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA. | Chief Tech/Sci/R&D Officer | 01.01.2023 |
| PRESBIA PLC | Chief Tech/Sci/R&D Officer | 02.01.2017 |
Ausbildung von Magda Michna
| University of Melbourne | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| STAAR SURGICAL COMPANY | Health Technology |
| PRESBIA PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
AcuFocus, Inc.
AcuFocus, Inc. Medical SpecialtiesHealth Technology AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA. | Health Technology |
